Single User License
INR 168725
Site License
INR 337450
Corporate User License
INR 506175

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Asthma-Pipeline Review, H1 2015

Asthma-Pipeline Review, H1 2015


  Request for Sample Report

Executive Summary

Asthma-Pipeline Review, H1 2015

Summary

Global Markets Direct's, 'Asthma-Pipeline Review, H1 2015', provides an overview of the Asthma's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Asthma and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global therapeutic landscape of Asthma

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Asthma and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Asthma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Asthma pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Asthma

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Asthma pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

Table of Contents 2

Introduction 9

Asthma Overview 10

Therapeutics Development 11

Asthma-Therapeutics under Development by Companies 13

Asthma-Therapeutics under Investigation by Universities/Institutes 26

Asthma-Pipeline Products Glance 28

Asthma-Products under Development by Companies 32

Asthma-Products under Investigation by Universities/Institutes 51

Asthma-Companies Involved in Therapeutics Development 53

Asthma-Therapeutics Assessment 195

Drug Profiles 214

Asthma-Recent Pipeline Updates 580

Asthma-Dormant Projects 684

Asthma-Discontinued Products 711

Asthma-Product Development Milestones 719

Appendix 728

List of Tables

Number of Products under Development for Asthma, H1 2015 41

Number of Products under Development for Asthma-Comparative Analysis, H1 2015 42

Number of Products under Development by Companies, H1 2015 44

Number of Products under Development by Companies, H1 2015 (Contd..1) 45

Number of Products under Development by Companies, H1 2015 (Contd..2) 46

Number of Products under Development by Companies, H1 2015 (Contd..3) 47

Number of Products under Development by Companies, H1 2015 (Contd..4) 48

Number of Products under Development by Companies, H1 2015 (Contd..5) 49

Number of Products under Development by Companies, H1 2015 (Contd..6) 50

Number of Products under Development by Companies, H1 2015 (Contd..7) 51

Number of Products under Development by Companies, H1 2015 (Contd..8) 52

Number of Products under Development by Companies, H1 2015 (Contd..9) 53

Number of Products under Development by Companies, H1 2015 (Contd..10) 54

Number of Products under Development by Companies, H1 2015 (Contd..11) 55

Number of Products under Investigation by Universities/Institutes, H1 2015 56

Comparative Analysis by Late Stage Development, H1 2015 58

Comparative Analysis by Clinical Stage Development, H1 2015 59

Comparative Analysis by Early Stage Development, H1 2015 60

Comparative Analysis by Unknown Stage Development, H1 2015 61

Products under Development by Companies, H1 2015 62

Products under Development by Companies, H1 2015 (Contd..1) 63

Products under Development by Companies, H1 2015 (Contd..2) 64

Products under Development by Companies, H1 2015 (Contd..3) 65

Products under Development by Companies, H1 2015 (Contd..4) 66

Products under Development by Companies, H1 2015 (Contd..5) 67

Products under Development by Companies, H1 2015 (Contd..6) 68

Products under Development by Companies, H1 2015 (Contd..7) 69

Products under Development by Companies, H1 2015 (Contd..8) 70

Products under Development by Companies, H1 2015 (Contd..9) 71

Products under Development by Companies, H1 2015 (Contd..10) 72

Products under Development by Companies, H1 2015 (Contd..11) 73

Products under Development by Companies, H1 2015 (Contd..12) 74

Products under Development by Companies, H1 2015 (Contd..13) 75

Products under Development by Companies, H1 2015 (Contd..14) 76

Products under Development by Companies, H1 2015 (Contd..15) 77

Products under Development by Companies, H1 2015 (Contd..16) 78

Products under Development by Companies, H1 2015 (Contd..17) 79

Products under Development by Companies, H1 2015 (Contd..18) 80

Products under Investigation by Universities/Institutes, H1 2015 81

Products under Investigation by Universities/Institutes, H1 2015 (Contd..1) 82

Asthma-Pipeline by AB Science, H1 2015 83

Asthma-Pipeline by Adamis Pharmaceuticals Corporation, H1 2015 84

Asthma-Pipeline by Advinus Therapeutics Ltd., H1 2015 85

Asthma-Pipeline by Afferent Pharmaceuticals, Inc., H1 2015 86

Asthma-Pipeline by Ahn-Gook Pharmaceutical Co., Ltd., H1 2015 87

Asthma-Pipeline by Alba Therapeutics Corporation, H1 2015 88

Asthma-Pipeline by ALK-Abello A/S, H1 2015 89

Asthma-Pipeline by Allakos Inc., H1 2015 90

Asthma-Pipeline by Allergopharma Joachim Ganzer KG, H1 2015 91

Asthma-Pipeline by Amakem NV, H1 2015 92

Asthma-Pipeline by Amgen Inc., H1 2015 93

Asthma-Pipeline by AnaptysBio, Inc., H1 2015 94

Asthma-Pipeline by Antisense Therapeutics Limited, H1 2015 95

Asthma-Pipeline by Apellis Pharmaceuticals, Inc., H1 2015 96

Asthma-Pipeline by Aquinox Pharmaceuticals Inc., H1 2015 97

Asthma-Pipeline by ARA Healthcare Pvt. Ltd., H1 2015 98

Asthma-Pipeline by Ario Pharma Ltd, H1 2015 99

Asthma-Pipeline by Array BioPharma Inc., H1 2015 100

Asthma-Pipeline by Aslan Pharmaceuticals Pte. Ltd., H1 2015 101

Asthma-Pipeline by Asmacure Ltee, H1 2015 102

Asthma-Pipeline by Astellas Pharma Inc., H1 2015 103

Asthma-Pipeline by AstraZeneca PLC, H1 2015 104

Asthma-Pipeline by Asubio Pharma Co., Ltd., H1 2015 105

Asthma-Pipeline by Axikin Pharmaceuticals, Inc., H1 2015 106

Asthma-Pipeline by Basilea Pharmaceutica AG, H1 2015 107

Asthma-Pipeline by BioLineRx, Ltd., H1 2015 108

Asthma-Pipeline by Bioncotech Therapeutics S.L., H1 2015 109

Asthma-Pipeline by Biotec Pharmacon ASA, H1 2015 110

Asthma-Pipeline by BioTech Tools s.a., H1 2015 111

Asthma-Pipeline by Boehringer Ingelheim GmbH, H1 2015 112

Asthma-Pipeline by CalciMedica, Inc., H1 2015 113

Asthma-Pipeline by Carolus Therapeutics, Inc., H1 2015 114

Asthma-Pipeline by Cellceutix Corporation, H1 2015 115

Asthma-Pipeline by Cellular Biomedicine Group, Inc., H1 2015 116

Asthma-Pipeline by Celon Pharma Sp. z o.o., H1 2015 117

Asthma-Pipeline by Centrose Llc, H1 2015 118

Asthma-Pipeline by Chiesi Farmaceutici SpA, H1 2015 119

Asthma-Pipeline by Circassia Pharmaceuticals plc, H1 2015 120

Asthma-Pipeline by Cognosci, Inc., H1 2015 121

Asthma-Pipeline by Corridor Pharmaceuticals Inc., H1 2015 122

Asthma-Pipeline by CSL Limited, H1 2015 123

Asthma-Pipeline by Cytokinetics, Inc., H1 2015 124

Asthma-Pipeline by Daiichi Sankyo Company, Limited, H1 2015 125

Asthma-Pipeline by Dynavax Technologies Corporation, H1 2015 126

Asthma-Pipeline by Eucalyptus Ltd., H1 2015 127

Asthma-Pipeline by F. Hoffmann-La Roche Ltd., H1 2015 128

Asthma-Pipeline by Farmacija d.o.o. Tuzla, H1 2015 129

Asthma-Pipeline by Five Prime Therapeutics, Inc., H1 2015 130

Asthma-Pipeline by Foresee Pharmaceuticals, LLC, H1 2015 131

Asthma-Pipeline by Fountain Biopharma Inc., H1 2015 132

Asthma-Pipeline by GeneFrontier Corporation, H1 2015 133

Asthma-Pipeline by Genentech, Inc., H1 2015 134

Asthma-Pipeline by GlaxoSmithKline plc, H1 2015 135

Asthma-Pipeline by Glenmark Pharmaceuticals Ltd., H1 2015 136

Asthma-Pipeline by GlycoMar Limited, H1 2015 137

Asthma-Pipeline by Griffin Discoveries BV, H1 2015 138

Asthma-Pipeline by Han Wha Pharma Co., Ltd., H1 2015 139

Asthma-Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2015 140

Asthma-Pipeline by Hanwha Chemical Corporation, H1 2015 141

Asthma-Pipeline by High Point Pharmaceuticals, LLC, H1 2015 142

Asthma-Pipeline by Histocell S.L., H1 2015 143

Asthma-Pipeline by Hydra Biosciences, Inc., H1 2015 144

Asthma-Pipeline by iCeutica, Inc., H1 2015 145

Asthma-Pipeline by iCo Therapeutics Inc., H1 2015 146

Asthma-Pipeline by Immupharma Plc, H1 2015 147

Asthma-Pipeline by Infinity Pharmaceuticals, Inc., H1 2015 148

Asthma-Pipeline by INOXIA Lifesciences GmbH, H1 2015 149

Asthma-Pipeline by Invion Limited, H1 2015 150

Asthma-Pipeline by ISU ABXIS Co.,Ltd., H1 2015 151

Asthma-Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H1 2015 152

Asthma-Pipeline by Johnson & Johnson, H1 2015 153

Asthma-Pipeline by Kineta, Inc., H1 2015 154

Asthma-Pipeline by Kissei Pharmaceutical Co., Ltd., H1 2015 155

Asthma-Pipeline by Kolltan Pharmaceuticals, Inc., H1 2015 156

Asthma-Pipeline by Kyowa Hakko Kirin Co., Ltd., H1 2015 157

Asthma-Pipeline by Laboratoires Pierre Fabre SA, H1 2015 158

Asthma-Pipeline by Lead Discovery Center GmbH, H1 2015 159

Asthma-Pipeline by LegoChem Biosciences, Inc, H1 2015 160

Asthma-Pipeline by Lpath, Inc., H1 2015 161

Asthma-Pipeline by Marinomed Biotechnologie GmbH, H1 2015 162

Asthma-Pipeline by MedImmune, LLC, H1 2015 163

Asthma-Pipeline by Merck & Co., Inc., H1 2015 164

Asthma-Pipeline by Mesoblast Limited, H1 2015 165

Asthma-Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015 166

Asthma-Pipeline by Monosol Rx, LLC, H1 2015 167

Asthma-Pipeline by MSM Protein Technologies, Inc., H1 2015 168

Asthma-Pipeline by N30 Pharmaceuticals, H1 2015 169

Asthma-Pipeline by NeoPharm Co., Ltd., H1 2015 170

Asthma-Pipeline by NeoStem, Inc., H1 2015 171

Asthma-Pipeline by Nostrum Pharmaceuticals, LLC, H1 2015 172

Asthma-Pipeline by Novartis AG, H1 2015 173

Asthma-Pipeline by Nuvo Research Inc., H1 2015 174

Asthma-Pipeline by Omeros Corporation, H1 2015 175

Asthma-Pipeline by Ono Pharmaceutical Co., Ltd., H1 2015 176

Asthma-Pipeline by OPKO Health, Inc., H1 2015 177

Asthma-Pipeline by Orion Oyj, H1 2015 178

Asthma-Pipeline by Oxagen Limited, H1 2015 179

Asthma-Pipeline by Palatin Technologies, Inc., H1 2015 180

Asthma-Pipeline by Panacea Biotec Limited, H1 2015 181

Asthma-Pipeline by Panmira Pharmaceuticals, LLC., H1 2015 182

Asthma-Pipeline by Peptinnovate Limited, H1 2015 183

Asthma-Pipeline by Pfizer Inc., H1 2015 184

Asthma-Pipeline by PharmaLundensis AB, H1 2015 185

Asthma-Pipeline by Pharmaxis Limited, H1 2015 186

Asthma-Pipeline by Pieris AG, H1 2015 187

Asthma-Pipeline by Polyphor Ltd., H1 2015 188

Asthma-Pipeline by Portola Pharmaceuticals, Inc., H1 2015 189

Asthma-Pipeline by Promedior, Inc., H1 2015 190

Asthma-Pipeline by Prosonix Ltd, H1 2015 191

Asthma-Pipeline by Protectimmun GmbH, H1 2015 192

Asthma-Pipeline by Proteologics Ltd., H1 2015 193

Asthma-Pipeline by Pulmagen Therapeutics LLP, H1 2015 194

Asthma-Pipeline by Pulmatrix, Inc., H1 2015 195

Asthma-Pipeline by Qu Biologics Inc., H1 2015 196

Asthma-Pipeline by Re-Pharm Limited, H1 2015 197

Asthma-Pipeline by Receptos, Inc., H1 2015 198

Asthma-Pipeline by Regeneron Pharmaceuticals, Inc., H1 2015 199

Asthma-Pipeline by Respiratorius AB, H1 2015 200

Asthma-Pipeline by ReveraGen BioPharma, Inc., H1 2015 201

Asthma-Pipeline by Rhizen Pharmaceuticals SA, H1 2015 202

Asthma-Pipeline by Rottapharm SpA, H1 2015 203

Asthma-Pipeline by SK Chemicals Co., Ltd., H1 2015 204

Asthma-Pipeline by SkyePharma PLC, H1 2015 205

Asthma-Pipeline by Sparsha Pharma International Pvt. Ltd., H1 2015 206

Asthma-Pipeline by Spring Bank Pharmaceuticals, Inc., H1 2015 207

Asthma-Pipeline by Stallergenes S.A., H1 2015 208

Asthma-Pipeline by sterna biologicals Gmbh & Co KG, H1 2015 209

Asthma-Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H1 2015 210

Asthma-Pipeline by Sun Pharma Advanced Research Company Ltd., H1 2015 211

Asthma-Pipeline by Sunovion Pharmaceuticals Inc., H1 2015 212

Asthma-Pipeline by Takeda Pharmaceutical Company Limited, H1 2015 213

Asthma-Pipeline by Teva Pharmaceutical Industries Limited, H1 2015 214

Asthma-Pipeline by Theraclone Sciences, Inc., H1 2015 215

Asthma-Pipeline by Trimel BioPharma SRL, H1 2015 216

Asthma-Pipeline by Vectura Group plc, H1 2015 217

Asthma-Pipeline by Verona Pharma Plc, H1 2015 218

Asthma-Pipeline by Visionary Pharmaceuticals, Inc., H1 2015 219

Asthma-Pipeline by WhanIn Pharmaceutical Co., Ltd., H1 2015 220

Asthma-Pipeline by Xencor, Inc., H1 2015 221

Asthma-Pipeline by Yungjin Pharm Ind. Co., Ltd., H1 2015 222

Asthma-Pipeline by Zambon Company S.p.A., H1 2015 223

Asthma-Pipeline by Ziarco Pharma Ltd, H1 2015 224

Assessment by Monotherapy Products, H1 2015 225

Assessment by Combination Products, H1 2015 226

Number of Products by Stage and Target, H1 2015 228

Number of Products by Stage and Mechanism of Action, H1 2015 235

Number of Products by Stage and Route of Administration, H1 2015 241

Number of Products by Stage and Molecule Type, H1 2015 243

Asthma Therapeutics-Recent Pipeline Updates, H1 2015 610

Asthma-Dormant Projects, H1 2015 714

Asthma-Dormant Projects (Contd..1), H1 2015 715

Asthma-Dormant Projects (Contd..2), H1 2015 716

Asthma-Dormant Projects (Contd..3), H1 2015 717

Asthma-Dormant Projects (Contd..4), H1 2015 718

Asthma-Dormant Projects (Contd..5), H1 2015 719

Asthma-Dormant Projects (Contd..6), H1 2015 720

Asthma-Dormant Projects (Contd..7), H1 2015 721

Asthma-Dormant Projects (Contd..8), H1 2015 722

Asthma-Dormant Projects (Contd..9), H1 2015 723

Asthma-Dormant Projects (Contd..10), H1 2015 724

Asthma-Dormant Projects (Contd..11), H1 2015 725

Asthma-Dormant Projects (Contd..12), H1 2015 726

Asthma-Dormant Projects (Contd..13), H1 2015 727

Asthma-Dormant Projects (Contd..14), H1 2015 728

Asthma-Dormant Projects (Contd..15), H1 2015 729

Asthma-Dormant Projects (Contd..16), H1 2015 730

Asthma-Dormant Projects (Contd..17), H1 2015 731

Asthma-Dormant Projects (Contd..18), H1 2015 732

Asthma-Dormant Projects (Contd..19), H1 2015 733

Asthma-Dormant Projects (Contd..20), H1 2015 734

Asthma-Dormant Projects (Contd..21), H1 2015 735

Asthma-Dormant Projects (Contd..22), H1 2015 736

Asthma-Dormant Projects (Contd..23), H1 2015 737

Asthma-Dormant Projects (Contd..24), H1 2015 738

Asthma-Dormant Projects (Contd..25), H1 2015 739

Asthma-Dormant Projects (Contd..26), H1 2015 740

Asthma-Discontinued Products, H1 2015 741

Asthma-Discontinued Products (Contd..1), H1 2015 742

Asthma-Discontinued Products (Contd..2), H1 2015 743

Asthma-Discontinued Products (Contd..3), H1 2015 744

Asthma-Discontinued Products (Contd..4), H1 2015 745

Asthma-Discontinued Products (Contd..5), H1 2015 746

Asthma-Discontinued Products (Contd..6), H1 2015 747

Asthma-Discontinued Products (Contd..7), H1 2015 748

List of Figures

Number of Products under Development for Asthma, H1 2015 41

Number of Products under Development for Asthma-Comparative Analysis, H1 2015 42

Number of Products under Development by Companies, H1 2015 43

Number of Products under Investigation by Universities/Institutes, H1 2015 56

Comparative Analysis by Late Stage Development, H1 2015 58

Comparative Analysis by Clinical Stage Development, H1 2015 59

Comparative Analysis by Early Stage Products, H1 2015 60

Assessment by Monotherapy Products, H1 2015 225

Assessment by Combination Products, H1 2015 226

Number of Products by Top 10 Targets, H1 2015 227

Number of Products by Stage and Top 10 Targets, H1 2015 227

Number of Products by Top 10 Mechanism of Actions, H1 2015 234

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 234

Number of Products by Top 10 Routes of Administration, H1 2015 240

Number of Products by Stage and Top 10 Routes of Administration, H1 2015 240

Number of Products by Top 10 Molecule Types, H1 2015 242

Number of Products by Stage and Top 10 Molecule Types, H1 2015 242

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

AB Science

Adamis Pharmaceuticals Corporation

Advinus Therapeutics Ltd.

Afferent Pharmaceuticals, Inc.

Ahn-Gook Pharmaceutical Co., Ltd.

Alba Therapeutics Corporation

ALK-Abello A/S

Allakos Inc.

Allergopharma Joachim Ganzer KG

Amakem NV

Amgen Inc.

AnaptysBio, Inc.

Antisense Therapeutics Limited

Apellis Pharmaceuticals, Inc.

Aquinox Pharmaceuticals Inc.

ARA Healthcare Pvt. Ltd.

Ario Pharma Ltd

Array BioPharma Inc.

Aslan Pharmaceuticals Pte. Ltd.

Asmacure Ltee

Astellas Pharma Inc.

AstraZeneca PLC

Asubio Pharma Co., Ltd.

Axikin Pharmaceuticals, Inc.

Basilea Pharmaceutica AG

BioLineRx, Ltd.

Bioncotech Therapeutics S.L.

Biotec Pharmacon ASA

BioTech Tools s.a.

Boehringer Ingelheim GmbH

CalciMedica, Inc.

Carolus Therapeutics, Inc.

Cellceutix Corporation

Cellular Biomedicine Group, Inc.

Celon Pharma Sp. z o.o.

Centrose Llc

Chiesi Farmaceutici SpA

Circassia Pharmaceuticals plc

Cognosci, Inc.

Corridor Pharmaceuticals Inc.

CSL Limited

Cytokinetics, Inc.

Daiichi Sankyo Company, Limited

Dynavax Technologies Corporation

Eucalyptus Ltd.

F. Hoffmann-La Roche Ltd.

Farmacija d.o.o. Tuzla

Five Prime Therapeutics, Inc.

Foresee Pharmaceuticals, LLC

Fountain Biopharma Inc.

GeneFrontier Corporation

Genentech, Inc.

GlaxoSmithKline plc

Glenmark Pharmaceuticals Ltd.

GlycoMar Limited

Griffin Discoveries BV

Han Wha Pharma Co., Ltd.

Hanmi Pharmaceuticals, Co. Ltd.

Hanwha Chemical Corporation

High Point Pharmaceuticals, LLC

Histocell S.L.

Hydra Biosciences, Inc.

iCeutica, Inc.

iCo Therapeutics Inc.

Immupharma Plc

Infinity Pharmaceuticals, Inc.

INOXIA Lifesciences GmbH

Invion Limited

ISU ABXIS Co.,Ltd.

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Johnson & Johnson

Kineta, Inc.

Kissei Pharmaceutical Co., Ltd.

Kolltan Pharmaceuticals, Inc.

Kyowa Hakko Kirin Co., Ltd.

Laboratoires Pierre Fabre SA

Lead Discovery Center GmbH

LegoChem Biosciences, Inc

Lpath, Inc.

Marinomed Biotechnologie GmbH

MedImmune, LLC

Merck & Co., Inc.

Mesoblast Limited

Mitsubishi Tanabe Pharma Corporation

Monosol Rx, LLC

MSM Protein Technologies, Inc.

N30 Pharmaceuticals

NeoPharm Co., Ltd.

NeoStem, Inc.

Nostrum Pharmaceuticals, LLC

Novartis AG

Nuvo Research Inc.

Omeros Corporation

Ono Pharmaceutical Co., Ltd.

OPKO Health, Inc.

Orion Oyj

Oxagen Limited

Palatin Technologies, Inc.

Panacea Biotec Limited

Panmira Pharmaceuticals, LLC.

Peptinnovate Limited

Pfizer Inc.

PharmaLundensis AB

Pharmaxis Limited

Pieris AG

Polyphor Ltd.

Portola Pharmaceuticals, Inc.

Promedior, Inc.

Prosonix Ltd

Protectimmun GmbH

Proteologics Ltd.

Pulmagen Therapeutics LLP

Pulmatrix, Inc.

Qu Biologics Inc.

Re-Pharm Limited

Receptos, Inc.

Regeneron Pharmaceuticals, Inc.

Respiratorius AB

ReveraGen BioPharma, Inc.

Rhizen Pharmaceuticals SA

Rottapharm SpA

SK Chemicals Co., Ltd.

SkyePharma PLC

Sparsha Pharma International Pvt. Ltd.

Spring Bank Pharmaceuticals, Inc.

Stallergenes S.A.

sterna biologicals Gmbh & Co KG

Sumitomo Dainippon Pharma Co., Ltd.

Sun Pharma Advanced Research Company Ltd.

Sunovion Pharmaceuticals Inc.

Takeda Pharmaceutical Company Limited

Teva Pharmaceutical Industries Limited

Theraclone Sciences, Inc.

Trimel BioPharma SRL

Vectura Group plc

Verona Pharma Plc

Visionary Pharmaceuticals, Inc.

WhanIn Pharmaceutical Co., Ltd.

Xencor, Inc.

Yungjin Pharm Ind. Co., Ltd.

Zambon Company S.p.A.

Ziarco Pharma Ltd

Asthma Therapeutic Products under Development, Key Players in Asthma Therapeutics, Asthma Pipeline Overview, Asthma Pipeline, Asthma Pipeline Assessment


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com